Role of GPR55 during axon growth and target innervation

eNeuro

Volumn 2, Issue 5, 2015, Pages

  Cherif, Hosni ^a   Argaw, Anteneh ^a,b   Cécyre, Bruno ^a   Bouchard, Alex ^a   Gagnon, Jonathan ^a   Javadi, Pasha ^a   Desgent, Sébastien ^c   Mackie, Ken ^d   Bouchard, Jean François ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF MONTREAL   (Canada)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Axon guidance; Development; GPR55 receptor; Growth cone; Retinal ganglion cell; Vision

Indexed keywords

CANNABIDIOL; CANNABINOID RECEPTOR; CENTRAL NERVOUS SYSTEM AGENTS; GPR55 PROTEIN, MOUSE; LYSOPHOSPHATIDYLINOSITOL; LYSOPHOSPHOLIPID; O-1602 COMPOUND;

ANALOGS AND DERIVATIVES; ANIMAL; AXON; BRAIN CORTEX; CELL CULTURE; CELL ENLARGEMENT; CELL SIZE; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; GROWTH CONE; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; MALE; MESOCRICETUS; METABOLISM; NERVE CELL; PHYSIOLOGY; PSEUDOPODIUM; RETINA; VISUAL SYSTEM;

ANIMALS; AXONS; CANNABIDIOL; CELL ENLARGEMENT; CELL SIZE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CEREBRAL CORTEX; FEMALE; GROWTH CONES; LYSOPHOSPHOLIPIDS; MALE; MESOCRICETUS; MICE, KNOCKOUT; NEURONS; PSEUDOPODIA; RECEPTORS, CANNABINOID; RETINA; VISUAL PATHWAYS;

EID: 85010647327     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0011-15.2015     Document Type: Article

References (76)

1. Anavi-Goffer S, Baillie G, Irving AJ, Gertsch J, Greig IR, Pertwee RG, Ross RA (2012) Modulation of L-α-lysophosphatidylinositol/ GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids. J Biol Chem 287:91-104. CrossRef Medline
2. Andradas C, Caffarel MM, Pérez-Gómez E, Salazar M, Lorente M, Velasco G, Guzmán M, Sánchez C (2011) The orphan G proteincoupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene 30:245-252. CrossRef Medline
3. Argaw A, Duff G, Boire D, Ptito M, Bouchard JF (2008) Protein kinase A modulates retinal ganglion cell growth during development. Exp Neurol 211:494-502. CrossRef Medline
4. Argaw A, Duff G, Zabouri N, Cécyre B, Chainé N, Cherif H, Tea N, Lutz B, Ptito M, Bouchard JF (2011) Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance. J Neurosci 31:1489-1499. CrossRef Medline
5. Baker D, Pryce G, Davies WL, Hiley CR. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci. 2006; 27:1-4. CrossRef Medline
6. Balenga NA, Aflaki E, Kargl J, Platzer W, Schröder R, Blättermann S, Kostenis E, Brown AJ, Heinemann A, Waldhoer M (2011) GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res 21:1452-1469 CrossRef Medline
7. Barres BA, Silverstein BE, Corey DP, Chun LL (1988) Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1:791-803. Medline
8. Bhide PG, Frost DO (1991) Stages of growth of hamster retinofugal axons: implications for developing axonal pathways with multiple targets. J Neurosci 11:485-504. Medline
9. Billah MM, Lapetina EG (1982). Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore A23187. J Biol Chem. 257:5196.
10. Bjartmar L, Huberman AD, Ullian EM, Rentería RC, Liu X, Xu W, Prezioso J, Susman MW, Stellwagen D, Stokes CC, Cho R, Worley P, Malenka RC, Ball S, Peachey NS, Copenhagen D, Chapman B, Nakamoto M, Barres BA, Perin MS (2006) Neuronal pentraxins mediate synaptic refinement in the developing visual system. J Neurosci 26:6269-6281. CrossRef Medline
11. Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, Graier WF (2010) GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol 161:308. CrossRef Medline
12. Bottenstein J, Sato G (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci U S A 76:514-517 Medline
13. Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard JF (2013a) Rod photoreceptors express GPR55 in the adult vervet monkey retina. PLoS One 8:e81080. CrossRef Medline
14. Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard JF (2013b) Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina. J Comp Neurol 521:2399-2415. CrossRef Medline
15. Cantarella G, Scollo M, Lempereur L, Saccani-Jotti G, Basile F, Bernardini R (2011) Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells. Biochem Pharmacol 82:380. CrossRef Medline
16. Cécyre B, Zabouri N, Huppé-Gourgues F, Bouchard JF, Casanova C (2013) Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice. Invest Ophthalmol Vis Sci 54:8079-8090. CrossRef Medline
17. Chapman B (2000) Necessity for afferent activity to maintain eyespecific segregation in ferret lateral geniculate nucleus. Science 287:2479-2482. Medline
18. Clancy B, Darlington RB, Finlay BL (2001) Translating developmental time across mammalian species. Neuroscience 105:7-17. Medline
19. Coombs JL, Van Der List D, Chalupa LM (2007) Morphological Properties of Mouse Retinal Ganglion Cells During Postnatal Development. J Comp Neurol 503:803-814. CrossRef Medline
20. Duff G, Argaw A, Cecyre B, Cherif H, Tea N, Zabouri N, Casanova C, Ptito M, Bouchard JF (2013) Cannabinoid receptor CB2 modulates axon guidance. PLoS One 8:e70849. CrossRef Medline
21. Dupin I, Dahan M, Studer V (2013) Investigating axonal guidance with microdevice-based approaches. J Neurosci 33:17647-17655. CrossRef Medline
22. Erskine L, Herrera E (2007) The retinal ganglion cell axon’s journey: insights into molecular mechanisms of axon guidance. Dev Biol 308:1-14. CrossRef Medline
23. Ford LA, Roelofs AJ, Anavi-Goffer S, Mowat L, Simpson DG, Irving AJ, Rogers MJ, Rajnicek AM, Ross RA (2010) A role for L-alphalysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 160:762-771. CrossRef Medline
24. Frassetto LJ, Schlieve CR, Lieven CJ, Utter AA, Jones MV, Agarwal N, Levin LA (2006) Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest Ophthal Vis Sci 47:427-438. Cross- Ref
25. Godement P, Salaün J, Imbert M (1984) Prenatal and postnatal development of retinogeniculate and retinocollicular projections in the mouse. J Comp Neurol 230:552-575. CrossRef Medline
26. Grzelczyk A, Gendaszewska-Darmach E (2013). Novel bioactive glycerol-based lysophospholipids: new data: new insight into their function. Biochimie 95:667. CrossRef Medline
27. Guy AT, Nagatsuka Y, Ooashi N, Inoue M, Nakata A, Greimel P, Inoue A, Nabetani T, Murayama A, Ohta K, Ito Y, Aoki J, Hirabayashi Y, Kamiguchi H (2015) Glycerophospholipid regulation of modality specific sensory axon guidance in the spinal cord. Science 349:974-977. CrossRef
28. 2+ signaling and NFAT activation. FASEB J 23:183-193. CrossRef Medline
29. Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, et al (2010) GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol 160:604-614. CrossRef Medline
30. Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M (2011) Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Mol Endocrinol 25:1835-1848. CrossRef Medline
31. Henstridge CM (2012) Off-target cannabinoid effects mediated by GPR55. Pharmacology 89:179-187. CrossRef Medline
32. Hong SL, Deykin D (1981) The activation of phosphatidylinositolhydrolyzing phospholipase A2 during prostaglandin synthesis in transformed mouse BALB/3T3 cells. J Biol Chem 256:5215.
33. Hu G, Ren G, Shi Y (2011) The putative cannabinoid receptor GPR55 promotes cancer cell proliferation. Oncogene 30:139-141. Cross- Ref Medline
34. Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol. 2007; 152:825-831.
35. Kallendrusch S, Kremzow S, Nowicki M, Grabiec U, Winkelmann R, Benz A, Kraft R, Bechmann I, Dehghani F, Koch M. The G Protein- Coupled Receptor 55 Ligand l-αLysophosphatidylinositol Exerts Microglia-Dependent Neuroprotection After Excitotoxic Lesion. Glia. 2013 Nov;61(11):1822-1831.
36. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Abood ME (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem.;284(43):29817-29827. Cross- Ref Medline
37. Kotsikorou E, Madrigal KE, Hurst DP, Sharir H, Lynch DL, Heynen- Genel S, Milan LB, Chung TD, Seltzman HH, Bai Y, Caron MG, Barak L, Abood ME, Reggio PH. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry. 2011; 50(25):5633-5647. CrossRef Medline
38. Kumar A, Qiao Z, Kumar P, Song ZH (2012) Effects of palmitoylethanolamide on aqueous humor outflow. Invest Ophthalmol Vis Sci 53:4416-4425. CrossRef Medline
39. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, et al (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105:2699-2704. CrossRef Medline
40. Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li Y, Zimmer A, Göke B, Sharkey KA, Storr M (2013) A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology 71:255-263. CrossRef Medline
41. López EM, Tagliaferro P, Onaivi ES, López-Costa JJ (2011) Distribution of CB2 cannabinoid receptor in adult rat retina. Synapse 65:388-392. CrossRef Medline
42. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA (1995) Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15:805-819. Medline
43. Monet M, Gkika D, Lehen’kyi V, Pourtier A, Vanden Abeele F, Bidaux G, Juvin V, Rassendren F, Humez S, Prevarsakaya N (2009) Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation, Biochim Biophys Acta 1793:528-539. Cross- Ref Medline
44. Nagatsuka Y, Hara-Yokoyama M, Kasama T, Takekoshi M, Maeda F, Ihara S, Fujiwara S, Ohshima E, Ishii K, Kobayashi T, Shimizu K, Hirabayashi Y (2003) Carbohydrate-dependent signaling from the phosphatidylglucoside-based microdomain induces granulocytic differentiation of HL60 cells. Proc Natl Acad Sci U S A 100:7454-7459. CrossRef Medline
45. Obara Y, Ueno S, Yanagihata Y, Nakahata N (2011). Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells. PLoS One 6:e24284. CrossRef Medline
46. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun; 362:928-934. CrossRef Medline
47. Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 45:13-20. CrossRef Medline
48. Oka S, Ota R, Shima M, Yamashita A, Sugiura T (2010) GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun, 395:232-237. CrossRef Medline
49. Ono M, Murakami T, Kudo A, Isshiki M, Sawada H, et al (2001) Quantitative Comparison of anti-fading mounting media for confocal laser scanning microscopy. J Histochem Cytochem 49:305-312. Medline
50. Pertwee RG (2007) GPR55: a new member of the cannabinoid receptor clan? Br J Pharmacol 152:984-986. CrossRef Medline
51. Petitet F, Donlan M, Michel A (2006) GPR55 as a new cannabinoid receptor: still a long way to prove it. Chem Biol Drug Des 67:252-253. CrossRef Medline
52. Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A (2009) Differential changes in GPR55 during microglial cell activation. FEBS Lett 583:2071-2076. CrossRef Medline
53. Piñeiro R, Maffucci T, Falasca M (2011) The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 30:142-152. CrossRef Medline
54. Robinson SR, Dreher B (1990) The visual pathways of eutherian mammals and marsupials develop according to a common timetable. Brain Behav Evol 36:177-195. Medline
55. Rojo ML, Gaztelumendi AR, Fowler CJ (2012) Lysophosphatidylinositol stimulates [35S]GTPγS binding in the rat prefrontal cortex and hippocampus. Neurochem Res 37:1037-1042. CrossRef
56. Romero-Zerbo S. Y., Rafacho A., Diaz-Arteaga A., Suarez J., Quesada I., Imbernon M., et al. (2011). A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. J. Endocrinol. 211177-211185. CrossRef
57. Ross RA (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30:156-163. CrossRef Medline
58. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS (2011) Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118: e101-e111. CrossRef Medline
59. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092-1101. CrossRef Medline
60. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O’Dowd BF (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193-198. CrossRef
61. Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M (2011) The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis 17:1651-1664. CrossRef Medline
62. Smith DM, Waite M (1992) Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils. J Leukoc Biol 52:670-678. Medline
63. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K (2005) Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751. CrossRef
64. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SWM, Barres BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178. CrossRef
65. Sylantyev S, Jensen TP, Ross RA, Rusakov DA (2013) Cannabinoidand lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc Natl Acad Sci U S A 110:5193-5198. CrossRef Medline
66. Torborg CL, Feller MB (2004) Unbiased analysis of bulk axonal segregation patterns. J Neurosci Methods 135:17-26. CrossRef Medline
67. 2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor triggered repression. J Cell Sci 121:1704-1717. CrossRef Medline
68. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, Ross RA, Rogers MJ (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106:16511-16516. CrossRef Medline
69. Wu CS, Chen H, Sun H, Zhu J, Jew CP, Wager-Miller J, Straiker A, Spencer C, Bradshaw H, Mackie K, Lu HC (2013) GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. PLoS One 8:e60314. CrossRef Medline
70. Wu CS, Zhu J, Wager-Miller J, Wang S, O’Leary D, Monory K, Lutz B, Mackie K, Lu HC (2010) Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neurosci 32:693-706. CrossRef Medline
71. Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y (2000) Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 905:242. Medline
72. Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J, Xu Y (2001) Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem 290:302. CrossRef Medline
73. Xu Y, Xiao YJ, Baudhuin LM, Schwartz BM (2001) The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Investig 8:1--13. Medline
74. Yamashita A, Oka S, Tanikawa T, Hayashi Y, Nemoto-Sasaki Y, Sugiura T (2013) The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Prostaglandins Other Lipid Mediat 07:103 CrossRef Medline
75. Zangenehpour S, Chaudhuri A (2001) Neural activity profiles of the neocortex and superior colliculus after bimodal sensory stimulation. Cereb Cortex 11:924-935. Medline
76. Zoeller RA, Wightman PD, Anderson MS, Raetz CR (1987) Accumulation of lysophosphatidylinositol in RAW 264.7 macrophage tumor cells stimulated by lipid A precursors. J Biol Chem 262:17212. Medline